Global

  1. Global—English
  2. 中国—简体中文

Investor Relations

Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.

Corporate Governance Stock Information Disclosure Financials Presentations and Events Contact IR
HOME / Investor Relations / Financials
All 2022 2021

  1. INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022

  2. ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2021

  3. INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021

  4. ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020

Follow
Harbour BioMed
on WeChat

Copyright © 2022 Harbour BioMed. All Rights Reserved 沪ICP备19015946号-1

FAMILY SITE

中文
ENG